SCHEMBL14974552

SCHEMBL14974552

O=S(=O)(O)CCCCS(=O)(=O)O.[BaH2]

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.61
▸ PTGS1 P23219 1/20 0.50
▸ PDE4A P27815 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SLC6A6 P31641 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ EPHX2 P34913 1/20 0.36
▸ CA5A P35218 2/20 0.36
▸ CA5B Q9Y2D0 2/20 0.36
▸ TSHR P16473 2/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ NT5E P21589 1/20 0.31
▸ CA4 P22748 1/20 0.31
▸ CA6 P23280 1/20 0.31
▸ CA7 P43166 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35183 0.96 APP (0.65) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL1270542 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
Eprodisate SCHEMBL11909839 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL1270406 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL918633 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL10693026 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL563101 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL6695830 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL1270769 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL563945 0.92 APP (0.61) APPPTGS1PDE4ALMNASLC6A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12129239-B2 Method for producing methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2024-10-29 — — US disclosed
EP-4006020-B1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2024-09-25 — — EP disclosed
CN-114144407-B Process for producing cyclic disulfonate compound 住友精化株式会社 2024-02-13 — — CN disclosed
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2023-10-31 — — US disclosed
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 — — US disclosed
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 — — US disclosed
EP-4006020-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 — — EP disclosed
EP-4006019-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 — — EP disclosed
CN-114144406-A Method for producing methylene disulfonate compound 住友精化株式会社 2022-03-04 — — CN disclosed
CN-114144407-A Process for producing cyclic disulfonate compound 住友精化株式会社 2022-03-04 — — CN disclosed
EP-2610250-B1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2016-01-20 — — EP disclosed
US-8501966-B2 Method for producing a methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-08-06 — — US disclosed
EP-2610250-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co. Ltd. (JP) 2013-07-03 — — EP disclosed
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129239-B2 Method for producing methylene disulfonate compound TST, MPST, SQOR APP 4724/4885PTGS1 1297/4885PDE4A 4430/4885
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND STS, TST, SCLY APP 4256/4885PTGS1 1684/4885PDE4A 3360/4885
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND TST, MPST, SQOR APP 4724/4885PTGS1 1297/4885PDE4A 4430/4885
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND DHPS, ADH7, MPST APP 4300/4885PTGS1 1332/4885PDE4A 4339/4885
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound STS, TST, SCLY APP 4256/4885PTGS1 1684/4885PDE4A 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback